About
3.01EUR-0.01 -0.40%
Closed • Updated at 13:38 GMT+00:00Market Cap$277.17M
Volume291.8K
Beta0.62
RSI65.44
Oryzon Genomics Sa — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 29 2026
ORYZON to Participate in Upcoming Events in May and June
Mar 25 2026
ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance
Mar 23 2026
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Mar 12 2026
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Recent Videos

Oryzon pone fecha a su gran catalizador: iadademstat encara datos decisivos
May 21, 2026

Rewriting Disease Biology Through LSD1 Inhibition with Oryzon's Carlos Buesa, Ph.D.
Apr 23, 2026

ORYZON | NOVA DAWN: Official Trailer
Apr 17, 2026

Consultorio de Bolsa | Pepe Baynat señala especulación en Mexedia y dudas en Oryzon
Mar 26, 2026
Google Übersetzer